INSTANT STREAMING COURSE
Share:

A to Z of Supplier Management in the Medical Device Industry

This course strengthens the ability to qualify, audit, monitor, and control medical device suppliers under FDA QSR and ISO 13485 expectations. It helps professionals reduce supplier-related compliance exposure through structured oversight, audit planning, process controls, and supplier corrective action management. This Course is designed for professionals responsible for supplier oversight, quality compliance, manufacturing controls, and external partner management.

REGISTER FOR THE COURSE

US $190 per learner

30-Days Unlimited Streaming Access

/* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } /* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } .accordion-header::after { content: "◯"; font-size: 18px; transition: transform 0.25s ease; } .accordion-item.active .accordion-header::after { transform: rotate(90deg); }

REGISTER FOR THE COURSE

To Get 30-Day Access to ONLY this Course 

US $190 per learner
  • This course is Included in Subscription Pack
Subscription include access to entire Learning Library
/* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } /* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } .accordion-header::after { content: "◯"; font-size: 18px; transition: transform 0.25s ease; } .accordion-item.active .accordion-header::after { transform: rotate(90deg); }
  • Faculty
    Meena Chettiar
  • Duration
    90 Minutes
  • Course ID
    TF2674
  • Ask the Expert
    Included
  • Presentation Handout
    & Templates
  • Assessment
    & Certification Included

 

About the Course

Supplier management directly affects product quality, regulatory compliance, and manufacturing continuity in the medical device industry. FDA expectations for supplier oversight, supplier audits, and OEM management continue to increase, placing greater responsibility on organizations to maintain documented control over qualification, monitoring, corrective actions, and supplier performance. Quality System Regulation requirements and ISO 13485 obligations make supplier management a critical operational function rather than an administrative activity.


Effective supplier oversight requires consistent evaluation methods, audit planning, process capability assessment, and alignment between supplier controls and product quality expectations. This course addresses qualification criteria tied to quality systems, product development processes, ISO certifications, and supplier manufacturing quality plans. It also addresses supplier audit frequency, SCAR follow-up activities, statistical process control considerations, first article inspection requirements, supplier training expectations, and regulatory obligations associated with supplier changes in medical device operations.

  • Strengthen Supplier Oversight and Audit Readiness:

    Participants gain practical direction for qualifying and sustaining suppliers while meeting FDA and ISO 13485 expectations. The course clarifies supplier audit frequency decisions, SCAR follow-up requirements, and documentation practices that support inspection readiness. Greater scrutiny on OEMs and external providers makes consistent supplier controls increasingly important for maintaining compliance and product quality.

  • Improve Process Control and Supplier Quality Decisions:

    The course connects supplier quality activities with manufacturing capability, SPC expectations, CTQ criteria, and first article inspection requirements. Participants develop stronger judgment for assessing supplier process controls, manufacturing quality plans, and sample inspection capability. It also clarifies the supplier quality role in new product release authorization and managing supplier-driven regulatory changes.

Key Areas Covered

  • Supplier qualification criteria based on quality systems, product development processes, ISO certifications, and regulatory requirements
  • FDA Quality System Regulation (QSR) and ISO 13485 expectations for supplier management and OEM oversight
  • Supplier onboarding, sustaining activities, and supplier training aligned with quality expectations
  • Supplier audits, audit frequency criteria, audit reporting, and SCAR follow-up activities
  • First article inspection, SPC correlation, CTQ and CTC criteria, and supplier process capability assessment
  • Supplier process control methods and capability assessment for sample inspections
  • Supplier quality responsibilities for new product release authorization and supplier manufacturing quality plans
  • Oversight considerations for testing laboratories, sterilization facilities, and supplier-related regulatory changes

Who Must Attend

  • QA/QC Departments
  • Regulatory Affairs Departments
  • Manufacturing  Departments
  • Engineering  Departments
  • Supplier Quality and Audit Teams
  • Supply Chain Department 

Quality training, expert insights, and answers that matter. Know your Expert

MEENA CHETTIAR

Meena Chettiar is a Quality and Regulatory Manager with experience across pharmaceutical, medical device, and regulated manufacturing environments. Her background includes supplier auditing, CAPA coordination, GMP compliance, and quality system implementation at organizations including Covidien, Baxter Bio Surgery, and Teva Pharmaceuticals. She has served as a lead supplier and internal auditor in domestic and international compliance audits and teaches ASQ certification courses related to biomedical auditing, quality auditing, and organizational excellence.

If you would like to request a Proforma invoice to sign up for this course. please click here

Commonly Asked Questions About This Subject

The following questions address practical regulatory, compliance, validation, quality, operational, and inspection-related considerations commonly associated with this subject.

What evidence carries the greatest weight when defending a decision to continue using a supplier after repeated quality issues?

Continuing to use a supplier can be a defensible decision when it is supported by objective evidence showing that the associated risks remain understood and effectively controlled. During inspections, reviewers spend far less time discussing whether quality issues occurred than determining why the organization concluded the supplier remained acceptable.


Inspection concerns develop when supplier performance decisions rely on production demands, historical business relationships, or informal confidence rather than documented quality evidence. Reviewers typically examine trend data, nonconformance history, complaint information, corrective action effectiveness, process capability, incoming inspection results, and management oversight to determine whether the decision reflected a structured evaluation. Repeated supplier issues without documented escalation or revised oversight frequently become difficult to explain.


Documentation becomes considerably stronger when it demonstrates why continued approval was appropriate, what additional controls were implemented, how effectiveness was verified, and what conditions would trigger supplier requalification or disqualification. Decisions supported by measurable evidence consistently withstand greater regulatory scrutiny than those supported primarily by operational necessity.

How should organizations respond when supplier performance data conflicts with audit results?

A favorable supplier audit should never outweigh objective evidence showing declining supplier performance. During inspections, reviewers often compare audit conclusions with complaint trends, incoming inspection results, nonconformance data, delivery performance, SCAR history, and process capability to determine whether supplier oversight reflects actual operating conditions rather than isolated observations.


Inspection concerns arise when suppliers continue to receive satisfactory audit outcomes while operational data shows recurring quality problems. Reviewers expect to understand how conflicting information was evaluated, whether the audit scope overlooked emerging issues, and what additional oversight was introduced before deciding to maintain the supplier's approval status. Relying on the audit alone becomes difficult to defend when other quality indicators consistently point in a different direction.


Documentation carries greater weight when it explains how all available supplier performance data was considered, why conflicting evidence was resolved in a particular way, and what follow-up activities were implemented to verify the decision. Records demonstrating that supplier oversight adapts to changing performance provide substantially stronger inspection support than decisions based on audit results alone.

When should a supplier change trigger a new risk evaluation instead of routine change management?

A supplier change should trigger a new risk evaluation whenever it alters the assumptions supporting product quality, process capability, or regulatory compliance. The decision should depend on the potential impact of the change rather than how it is categorized within the quality system.


Inspection discussions often focus on supplier changes involving manufacturing locations, critical processes, subcontractors, raw material sources, sterilization providers, software used in production, or quality system ownership. Organizations sometimes process these changes administratively without evaluating whether existing product risks have changed. That approach weakens the ability to demonstrate that supplier oversight remains appropriate.


A defensible evaluation explains what changed, why the original risk assessment may or may not remain applicable, what evidence was reviewed, and whether additional verification activities became necessary. Reviewers place considerable value on documentation showing that supplier change management and product risk management operate together instead of as independent quality activities.

How should organizations demonstrate that supplier oversight remains effective between scheduled audits?

Supplier oversight should be demonstrated through continuous evaluation rather than relying on the successful completion of periodic audits. During inspections, reviewers frequently look beyond audit schedules to determine whether the organization recognized declining supplier performance before the next planned audit occurred.


Inspection concerns increase when supplier monitoring depends almost entirely on annual reviews while production records, complaint trends, incoming inspection results, process capability data, delivery performance, or corrective action effectiveness indicate deteriorating performance. Scheduled audits alone provide limited assurance when ongoing operational evidence points toward increasing supplier risk.


Oversight becomes substantially more defensible when documented supplier performance reviews incorporate multiple quality indicators and clearly explain how those indicators influence monitoring activities, escalation decisions, and management review. Evidence showing that supplier controls respond to changing performance carries considerably greater weight than records demonstrating that audit frequencies were simply maintained according to procedure.

Ready to Strengthen Your Team? Let’s Build Your Training Plan.

Whether you’re looking for a single onsite workshop or a multi-team training series, we’ll help you design a program that fits your goals, timelines, and operational reality.

Your team deserves the clarity.
Your organization deserves the confidence.

Upcoming Courses

Your TalkFDA Webinar Experience

When you reserve your seat, everything is organized for you — from access to certification from one place.

1. Confirmation

You receive a confirmation email and your course appears instantly in your TalkFDA dashboard.

2. Your Course Hub
Your TalkFDA course page becomes your central hub where you can watch the course, access materials, and manage your learning.

3. Access course materials
The presentation handout and other materials can be downloaded inside the Course Player. You could use Discussion feature there to ask your questions.

4. Watch The Streaming and Complete your Course
The course playback will be available on the same course page. You could pause and continue or you can revisit important sections.
5. Earn Your Certificate
Complete the course and your certificate is unlocked automatically in your learning history.

The challenge with training is rarely signing up. It’s what happens afterward, when access, materials, & certification aren’t accessible from one place.
With TalkFDA Courses, Everything you need Live in One Place.
Simple. Organized. Professional.
Go ahead and Take the Course with confidence.

Our students love us ❤️

“Structure helped. Otherwise this topic can get messy quickly.”


Validation Specialist, QA/IT

“Practical side was covered well. Not just theory.”


Engineer, Validation

“Support team followed up properly. That part is usually missing elsewhere.”

Supervisor, Training and Development

People who took this Course, also viewed